SK287931B6 - Triphasic oral contraceptive - Google Patents

Triphasic oral contraceptive Download PDF

Info

Publication number
SK287931B6
SK287931B6 SK887-2001A SK8872001A SK287931B6 SK 287931 B6 SK287931 B6 SK 287931B6 SK 8872001 A SK8872001 A SK 8872001A SK 287931 B6 SK287931 B6 SK 287931B6
Authority
SK
Slovakia
Prior art keywords
phase
estrogen
dosage units
women
study
Prior art date
Application number
SK887-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK8872001A3 (en
Inventor
Gary Shangold
Arkady Rubin
David Upmalis
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22349144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287931(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of SK8872001A3 publication Critical patent/SK8872001A3/sk
Publication of SK287931B6 publication Critical patent/SK287931B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK887-2001A 1998-12-23 1999-12-08 Triphasic oral contraceptive SK287931B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11339498P 1998-12-23 1998-12-23
PCT/US1999/029129 WO2000038691A1 (en) 1998-12-23 1999-12-08 Triphasic oral contraceptive

Publications (2)

Publication Number Publication Date
SK8872001A3 SK8872001A3 (en) 2002-03-05
SK287931B6 true SK287931B6 (sk) 2012-04-03

Family

ID=22349144

Family Applications (1)

Application Number Title Priority Date Filing Date
SK887-2001A SK287931B6 (sk) 1998-12-23 1999-12-08 Triphasic oral contraceptive

Country Status (26)

Country Link
US (2) US6214815B1 (ja)
EP (1) EP1140109B1 (ja)
JP (1) JP2002533398A (ja)
KR (1) KR100669165B1 (ja)
CN (1) CN100408040C (ja)
AR (1) AR028809A1 (ja)
AT (1) ATE318605T1 (ja)
AU (1) AU765153B2 (ja)
BR (1) BR9916579A (ja)
CA (1) CA2356747C (ja)
CY (1) CY1105276T1 (ja)
CZ (1) CZ302568B6 (ja)
DE (1) DE69930157T2 (ja)
DK (1) DK1140109T3 (ja)
ES (1) ES2259481T3 (ja)
HU (1) HU229251B1 (ja)
MX (1) MXPA01006533A (ja)
NO (1) NO321118B1 (ja)
NZ (1) NZ512404A (ja)
PL (1) PL196715B1 (ja)
PT (1) PT1140109E (ja)
RU (1) RU2225207C2 (ja)
SK (1) SK287931B6 (ja)
TR (1) TR200101826T2 (ja)
WO (1) WO2000038691A1 (ja)
ZA (1) ZA200106006B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
HUP9900213A1 (hu) * 1999-02-01 2000-12-28 Gábor Bogye Gyógykompozíció(k) gesztagén tipusú hormon tartalmú gyógyszerek thromb-embóliás mellékhatásainak mérséklésére
US20060281723A1 (en) * 1999-04-16 2006-12-14 Kafrissen Michael E Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
EP1390040B1 (en) * 2001-05-18 2007-01-03 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
ATE449606T1 (de) * 2001-05-23 2009-12-15 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
DE60223795T2 (de) * 2001-05-23 2008-11-27 Pantarhei Bioscience B.V. Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption
US20040202713A1 (en) * 2001-05-23 2004-10-14 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
ES2278925T3 (es) * 2001-11-15 2007-08-16 Pantarhei Bioscience B.V. Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal.
WO2003049744A1 (en) 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
WO2003103685A1 (en) * 2002-06-11 2003-12-18 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
CN1691947B (zh) * 2002-06-11 2011-11-23 潘塔希生物科学股份有限公司 雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
PT1526856E (pt) 2002-07-12 2008-04-11 Pantarhei Bioscience Bv Composição farmacêutica que compreende derivados do estretol para ser utilizada no tratamento do cancro
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
SI1556058T1 (sl) * 2002-10-23 2008-02-29 Pantarhei Bioscience Bv Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
JP2006525358A (ja) 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
EP1673094A1 (en) * 2003-10-01 2006-06-28 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
BRPI0516247A (pt) * 2004-10-07 2008-08-26 Duramed Pharmaceuticals Inc métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
CA2674325A1 (en) * 2007-01-08 2008-07-17 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
DE102007011486A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Arzneimittel umfassend wenigstens ein Gestagen
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
ES2795455T3 (es) 2008-10-08 2020-11-23 Agile Therapeutics Inc Suministro transdérmico
ES2734510T3 (es) 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
WO2010111488A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US20170035781A1 (en) 2015-06-22 2017-02-09 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3836651A (en) 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2310963A1 (de) 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3969502A (en) 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
US3932635A (en) 1972-04-24 1976-01-13 Syntex Corporation Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4291028A (en) 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
USRE35724E (en) 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4962098A (en) 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
US5023084A (en) 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US4948593A (en) 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5453279A (en) 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5747480A (en) 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
ZA200106006B (en) 2002-10-21
CY1105276T1 (el) 2010-03-03
PL196715B1 (pl) 2008-01-31
ES2259481T3 (es) 2006-10-01
EP1140109A1 (en) 2001-10-10
CZ20012184A3 (cs) 2003-01-15
NO20013144D0 (no) 2001-06-22
MXPA01006533A (es) 2002-06-04
PT1140109E (pt) 2006-05-31
CZ302568B6 (cs) 2011-07-13
US20010044429A1 (en) 2001-11-22
CN100408040C (zh) 2008-08-06
CA2356747A1 (en) 2000-07-06
DE69930157D1 (de) 2006-04-27
JP2002533398A (ja) 2002-10-08
WO2000038691A1 (en) 2000-07-06
NO20013144L (no) 2001-08-23
AU765153B2 (en) 2003-09-11
CN1334734A (zh) 2002-02-06
AR028809A1 (es) 2003-05-28
US6214815B1 (en) 2001-04-10
AU1936500A (en) 2000-07-31
EP1140109B1 (en) 2006-03-01
KR20010081087A (ko) 2001-08-25
ATE318605T1 (de) 2006-03-15
BR9916579A (pt) 2001-10-02
DK1140109T3 (da) 2006-05-15
TR200101826T2 (tr) 2001-12-21
SK8872001A3 (en) 2002-03-05
KR100669165B1 (ko) 2007-01-17
NO321118B1 (no) 2006-03-20
DE69930157T2 (de) 2006-08-31
HUP0104680A3 (en) 2002-06-28
CA2356747C (en) 2005-09-27
NZ512404A (en) 2003-08-29
HU229251B1 (en) 2013-10-28
HUP0104680A2 (hu) 2002-04-29
RU2225207C2 (ru) 2004-03-10

Similar Documents

Publication Publication Date Title
SK287931B6 (sk) Triphasic oral contraceptive
CA2188907C (en) Combination compound for contraception based on natural estrogen
AU2008237614B2 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
JP3314207B2 (ja) ホルモン製剤及び方法
US20050113350A1 (en) Extended use combination comprising estrogens and progestins
US20050038006A1 (en) Triphasic oral contraceptive
DI CARLO et al. Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting.

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20191208